Literature DB >> 27697090

Overexpression of SCUBE2 Inhibits Proliferation, Migration, and Invasion in Glioma Cells.

Erkun Guo, Hongjiang Liu, Xiaopeng Liu.   

Abstract

Signal peptide CUB EGF-like domain-containing protein 2 (SCUBE2), a member of the SCUBE family of proteins, was recently found to play an important role in cancer development. However, little is known regarding its biological function in glioma. In the present study, we investigated the effect of SCUBE2 on glioma and explored its relevant mechanisms. The study showed that SCUBE2 had a low expression in glioma tissue and cell lines. SCUBE2 overexpression inhibited glioma cell proliferation in vitro and in vivo as well as suppressed glioma cell migration and invasion in vitro. Furthermore, we found that the Sonic hedgehog (Shh) signaling pathway was involved in the inhibitory effect of SCUBE2 overexpression on glioma cells. In light of the results obtained from our study, SCUBE2 may be regarded as a potential therapeutic target for glioma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27697090     DOI: 10.3727/096504016X14747335734344

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  5 in total

Review 1.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

Review 2.  Cancer stem cells: a major culprit of intra-tumor heterogeneity.

Authors:  Faiza Naz; Mengran Shi; Salvia Sajid; Zhao Yang; Changyuan Yu
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

3.  Methylation-induced downregulation and tumor-suppressive role of microRNA-98 in glioma through targeting Sal-like protein 4.

Authors:  Zhiwei Xia; Dongxu Qiu; Jun Deng; Xiao Jiao; Ronghe Yang; Zhongyi Sun; Xin Wan; Jing Li
Journal:  Int J Mol Med       Date:  2018-02-06       Impact factor: 4.101

4.  Estrogen receptor-positive breast cancer survival prediction and analysis of resistance-related genes introduction.

Authors:  Chen Shuai; Fengyan Yuan; Yu Liu; Chengchen Wang; Jiansong Wang; Hongye He
Journal:  PeerJ       Date:  2021-10-26       Impact factor: 2.984

Review 5.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.